Andrew Huberman· PhD
And so people have done studies with psilocybin, and now there's some studies with MDMA trying to look at treating OCD, you know, with this same sort of idea of letting go, right?
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And so people have done studies with psilocybin, and now there's some studies with MDMA trying to look at treating OCD, you know, with this same sort of idea of letting go, right?
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.